Orange Book product · Generic (ANDA)
ETOMIDATE
ETOMIDATE
At a glance
Feb 07, 2017
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 07, 2017
9 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
ETOMIDATE
Strength
2MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 201044
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ETOMIDATE
- 1982AMIDATEBrand (NDA)
NDA 018227 · HOSPIRA
- 2020ETOMIDATEGeneric (ANDA)
ANDA 215028 · CAPLIN
- 2017ETOMIDATEGeneric (ANDA)
ANDA 209058 · GLAND
- 2017ETOMIDATEGeneric (ANDA)
ANDA 206126 · EUGIA PHARMA
- 2016ETOMIDATEGeneric (ANDA)
ANDA 202354 · HIKMA
- 2014ETOMIDATEGeneric (ANDA)
ANDA 204618 · AVET LIFESCIENCES
- 2014ETOMIDATEGeneric (ANDA)
ANDA 202360 · ZYDUS PHARMS
- 2012ETOMIDATEGeneric (ANDA)
ANDA 091297 · PH HEALTH
- 2009ETOMIDATEGeneric (ANDA)
ANDA 078867 · LUITPOLD
- 2009ETOMIDATEGeneric (ANDA)
ANDA 078289 · RISING
- 1996ETOMIDATEGeneric (ANDA)
ANDA 074593 · HIKMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
